Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.

Tristan Ferry; Agathe Sénéchal; Marie-Claude Gagnieu; André Boibieux; Frédéric Laurent; Thomas Perpoint; Michel Tod; Christian Chidiac

doi:10.1016/j.jinf.2012.09.004

Journal articles

Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.: Prolonged high-dose ertapenem in BJI

Tristan Ferry ^{1, 2, *} Agathe Sénéchal ² Marie-Claude Gagnieu ² André Boibieux ² Frédéric Laurent ^{1, 2} Thomas Perpoint ² Michel Tod ² Christian Chidiac ²

* Corresponding author

1 I2V - Immunité infection vaccination

2 Service de Maladies Infectieuses et Tropicales [Hôpital de la Croix-Rousse - HCL]

Résumé : n.a

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology / Infectious diseases

Complete list of metadata

Cited literature [4 references] Display Hide Download

https://www.hal.inserm.fr/inserm-00734708
Contributor : Tristan Ferry Connect in order to contact the contributor
Submitted on : Monday, September 24, 2012 - 2:18:25 PM
Last modification on : Tuesday, January 21, 2020 - 2:52:29 PM
Long-term archiving on: : Friday, December 16, 2016 - 3:43:31 PM

Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.: Prolonged high-dose ertapenem in BJI

File

Restricted access

Identifiers

Collections

Citation

Export

Metrics

86

Prolonged subcutaneous high dose (1 g bid) of Ertapenem as salvage therapy in patients with difficult-to-treat bone and joint infection.: Prolonged high-dose ertapenem in BJI

File

Restricted access

Identifiers

Collections

Citation

Export

Share

Metrics

86